Back to Results
First PageMeta Content
Angiology / Vascular endothelial growth factor / Ranibizumab / Bevacizumab / Macular degeneration / Choroidal neovascularization / Genentech / Diabetic retinopathy / Retinal haemorrhage / Medicine / Ophthalmology / Vision


Supplement to November/December 2014 CME ACTIVITY
Add to Reading List

Document Date: 2014-12-18 14:21:55

Open Document

File Size: 1,19 MB

Share Result on Facebook

City

Orlando / Houston / Cleveland Clinic Cleveland / Baltimore / Philadelphia / Washington / D.C. / New Orleans / Miami / /

Company

Novartis International AG / Alexion Pharmaceuticals / Genentech / Valeant Pharmaceuticals International / Optos / Bayer AG / Allergan Inc / ThromboGenics NV / Regeneron Pharmaceuticals / RISE Research Group / /

Currency

AMD / /

Event

FDA Phase / /

Facility

National Eye Institute / Cosmetic Surgery Center Mercy Medical Center / Ophthalmology Cleveland Clinic Lerner College / Clinic Cleveland / Clinical Ophthalmology University of Miami Bascom Palmer Eye Institute Miami / Vitreoretinal Department Cole Eye Institute / Clinical Trials Unit University of Southern California Los Angeles / /

IndustryTerm

products/ devices / therapies for common retinal diseases / insurance / Online Courses / retinal disease therapy / home-monitoring device / imaging / treatment of retinal diseases / pharmaceuticals / home-monitoring devices / product/device / services / /

MedicalCondition

scar / DF / macular edema / JE / retinal diseases / macular degeneration / ischemic heart disease / metamorphopsia / common retinal diseases / choroidal neovascularization / expected disease / chronic condition / hypertension / cancer / disease / focal aneurysm / disciform scar / hypercholesterolemia / thyroid disorder / treatmentresistant neovascular age-related macular degeneration / cardiovascular disease / diabetes / unilateral age-related macular degeneration / neovascular age-related macular degeneration / common ocular disease / retinal disease / endophthalmitis NOVEMBER/DECEMBER / diseases / diabetic macular edema / II diabetes mellitus / retinal vein occlusion / cataract / /

MedicalTreatment

vitamin therapy / retreatment / photodynamic therapy / drug therapy / /

Organization

National Eye Institute / Accreditation Council for Continuing Medical Education / Cornell / Clinical Trials Unit University of Southern California Los Angeles / American Academy of Ophthalmology / Ophthalmology Cleveland Clinic Lerner College of Medicine / Vitreoretinal Department Cole Eye Institute / Retina / US Food and Drug Administration / Dulaney Foundation / FDA / TX FACULTY / Clinical Ophthalmology University of Miami Bascom Palmer Eye Institute Miami / /

Person

Peter K. Kaiser / Thomas Albini / Systemic Impact Peter Kaiser / Chong V / Charles C. Wykoff / Andrew Moshfeghi / Ross Lakhanpal / Zhu M. Intravitreal / Audina Berrocal / Rohit Ross Lakhanpal / Arch Ophthalmol / Moderator Thomas Albini / Yang Y. Bilateral / /

Position

Specialist / Staff Surgeon / referring physician / Professor / Director / Assistant Professor / Associate Professor / /

Product

dexamethasone / Avastin / Lucentis / Ozurdex / indocyanine green / GS / DV / using Ozurdex / This supplement / /

ProvinceOrState

Virginia / Florida / /

PublishedMedium

Ophthalmology / /

Region

Southern California / /

Technology

tomography / smartphone / TAE protocol / laser / OCT-based algorithm / /

URL

http /

SocialTag